SCHEMBL17876206

SCHEMBL17876206

CC1(C)Oc2ccc(-c3cc(-c4cccnc4)cc(-c4cccnc4)c3)cc2-c2cc(-c3cccc4oc5ccccc5c34)ccc2O1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 4/20 0.44
KCNH2 Q12809 2/20 0.44
PGR P06401 1/20 0.38
CYP11B1 P15538 4/20 0.37
CYP11B2 P19099 3/20 0.37
CYP19A1 P11511 3/20 0.35
CYP17A1 P05093 1/20 0.34
PDK2 Q15119 1/20 0.34
PDE10A Q9Y233 1/20 0.34
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CTSD P07339 1/20 0.33
DHFR P00374 1/20 0.33
NPC1 O15118 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876169 0.96 BACE1 (0.41) BACE1KCNH2PGRCYP11B1CYP11B2
SCHEMBL17876171 0.96 BACE1 (0.41) BACE1KCNH2PGRCYP11B1CYP11B2
SCHEMBL17876193 0.90 ALOX5 (0.45) BACE1KCNH2PGRCYP11B1CYP11B2
SCHEMBL17876203 0.89 BACE1 (0.42) BACE1KCNH2PGRCYP11B1CYP11B2
SCHEMBL17876198 0.89 BACE1 (0.42) BACE1KCNH2PGRCYP11B1CYP11B2
SCHEMBL17876208 0.88 PLA2G2A (0.38) PGRCYP19A1KDM4EALDH1A1MAPT
SCHEMBL17876163 0.86 ALOX5 (0.42) BACE1KCNH2PGRCYP11B1CYP11B2
SCHEMBL17876130 0.86 ALOX5 (0.42) BACE1KCNH2PGRCYP11B1CYP11B2
SCHEMBL17876167 0.86 BACE1 (0.39) BACE1KCNH2PGRCYP11B1CYP11B2
SCHEMBL17876135 0.86 BACE1 (0.39) BACE1KCNH2PGRCYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 BACE1 709/4885KCNH2 2189/4885PGR 1766/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 BACE1 709/4885KCNH2 2189/4885PGR 1766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.